Cardiovascular Biomarkers in Exhaled Breath

Progress in Cardiovascular Diseases

Volumn 55, Issue 1, 2012, Pages 34-43

  Cikach, Frank S ^a   Dweik, Raed A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ACRYLONITRILE; ALCOHOL; BENZENE; BIOLOGICAL MARKER; CARBON DIOXIDE; CARBON MONOXIDE; CHEMOKINE; CHOLESTEROL; CORTICOSTEROID; CYTOKINE; ENDOTHELIN RECEPTOR ANTAGONIST; ETHANE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENE; METHANE; MEVALONIC ACID; NITRIC OXIDE; PENTANE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; VOLATILE ORGANIC COMPOUND;

ACUTE HEART INFARCTION; ANALYTIC METHOD; BREATH ANALYSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; DRUG TARGETING; END TIDAL CARBON DIOXIDE TENSION; ENZYME INHIBITION; HEART FAILURE; HUMAN; INTESTINE FLORA; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; OXIDATIVE STRESS; PROTON TRANSFER REACTION MASS SPECTROMETRY; PULMONARY HYPERTENSION; QUANTUM CASCADE LASER; REVIEW; SELECTED ION FLOW TUBE MASS SPECTROMETRY;

EID: 84864070195     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.05.005     Document Type: Article

References (75)

1. Dweik R.A., Amann A. Exhaled breath analysis: the new frontier in medical testing. J Breath Res 2008, 030301.
2. Phillips M., Herrera J., Krishnan S., et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 1999, 729:75-88.
3. Grob N.M., Aytekin M., Dweik R.A. Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res 2008, 037004.
4. Almstrand A.C., Ljungstrom E., Lausmaa J., et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Anal Chem 2009, 81:662-668.
5. Mashir A., Dweik R.A. Exhaled breath analysis: the new interface between medicine and engineering. Adv Powder Technol 2009, 20:420-425.
6. Phillips M., Cataneo R.N., Ditkoff B.A., et al. Volatile markers of breast cancer in the breath. Breast J 2003, 9:184-191.
7. Phillips M., Boehmer J.P., Cataneo R.N., et al. Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study). J Heart Lung Transplant 2004, 23:701-708.
8. Sylvester K.P., Patey R.A., Rafferty G.F., et al. Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr 2005, 164:162-165.
9. Machado R.F., Laskowski D., Deffenderfer O., et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005, 171:1286-1291.
10. Gustafsson L.E., Leone A.M., Persson M.G., et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991, 181:852-857.
11. Dweik R.A., Comhair S.A., Gaston B., et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA 2001, 98:2622-2627.
12. Dweik R.A., Laskowski D., Abu-Soud H.M., et al. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998, 101:660-666.
13. Khatri S.B., Hammel J., Kavuru M.S., et al. Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. J Appl Physiol 2003, 95:436-440. [discussion 5].
14. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999, 160:2104-2117.
15. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912-930.
16. Smith A.D., Cowan J.O., Brassett K.P., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163-2173.
17. Dweik R.A., Sorkness R.L., Wenzel S., et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010, 181:1033-1041.
18. Grob N.M., Dweik R.A. Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet?. Chest 2008, 133:837-839.
19. Silkoff P.E., Carlson M., Bourke T., et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004, 114:1241-1256.
20. Dweik R.A., Boggs P.B., Erzurum S.C., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011, 184:602-615.
21. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987, 84:9265-9269.
22. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
23. Dweik R.A., Erzurum S.C. Regulation of nitric oxide (NO) synthases and gas phase NO by oxygen. Disease markers in exhaled breath (lung biology in health and disease) 2003, 235-246. Marcel Dekker, Inc., New York, NY. N. Marczin, S.A. Kharitonov, M.H. Yacoub, P.J. Barnes (Eds.).
24. Kaneko F.T., Arroliga A.C., Dweik R.A., et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 1998, 158:917-923.
25. Kharitonov S.A., Yates D., Robbins R.A., et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
26. Silkoff P.E., McClean P., Spino M., et al. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001, 119:1322-1328.
27. Ozkan M., Dweik R.A. Nitric oxide and airway reactivity. Clin Pulm Med 2001, 8:199-206.
28. Archer S., Rich S. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". Circulation 2000, 102:2781-2791.
29. Dweik R. Pulmonary hypertension and the search for the selective pulmonary vasodilator. Lancet 2002, 360:886.
30. Dweik R.A. The lung in the balance: arginine, methylated arginines, and nitric oxide. Am J Physiol Lung Cell Mol Physiol 2007, 292:L15-L17.
31. Ozkan M., Dweik R.A., Laskowski D., et al. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung 2001, 179:233-243.
32. Girgis R.E., Frost A.E., Hill N.S., et al. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis 2007, 66:1467-1472.
33. Machado R.F., Londhe Nerkar M.V., Dweik R.A., et al. Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic Biol Med 2004, 37:1010-1017.
34. Barnes P.J., Dweik R.A., Gelb A.F., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010, 138:682-692.
35. Villamor E., Perez-Vizcaino F., Cogolludo A.L., et al. Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 2000, 48:546-553.
36. Zelis R., Nellis S.H., Longhurst J., et al. Abnormalities in the regional circulations accompanying congestive heart failure. Prog Cardiovasc Dis 1975, 18:181-199.
37. Winlaw D.S., Smythe G.A., Keogh A.M., et al. Increased nitric oxide production in heart failure. Lancet 1994, 344:373-374.
38. Habib F., Dutka D., Crossman D., et al. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?. Lancet 1994, 344:371-373. [see comments].
39. Seshadri N., Dweik R.A., Laskowski D., et al. Dysregulation of endogenous carbon monoxide and nitric oxide production in patients with advanced ischemic or nonischemic cardiomyopathy. Am J Cardiol 2003, 92:820-823.
40. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37:517-554.
41. Wang R., Wang Z., Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 1997, 121:927-934.
42. Motterlini R., Gonzales A., Foresti R., et al. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998, 83:568-577. [erratum appears in Circ Res 1998;83:1289].
43. Sammut I.A., Foresti R., Clark J.E., et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 1998, 125:1437-1444.
44. Togane Y., Morita T., Suematsu M., et al. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 2000, 278:H623-H632.
45. Otterbein L.E., Bach F.H., Alam J., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000, 6:422-428.
46. Clark J.E., Foresti R., Sarathchandra P., et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000, 278:H643-H651.
47. Sato K., Balla J., Otterbein L., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001, 166:4185-4194.
48. Brouard S., Otterbein L.E., Anrather J., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000, 192:1015-1026.
49. Wagner C.T., Durante W., Christodoulides N., et al. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997, 100:589-596.
50. Kharitonov S.A., Barnes P.J. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001, 163:1693-1722.
51. St Croix C.M., Wetter T.J., Pegelow D.F., et al. Assessment of nitric oxide formation during exercise. Am J Respir Crit Care Med 1999, 159:1125-1133.
52. Biban P., Zangardi T., Baraldi E., et al. Mixed exhaled nitric oxide and plasma nitrites and nitrates in newborn infants. Life Sci 2001, 68:2789-2797.
53. Thorup C., Jones C.L., Gross S.S., et al. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 1999, 277:F882-F889.
54. Risby T.H., Tittel F.K. Current status of midinfrared quantum and interband cascade lasers for clinical breath analysis. Opt Eng 2010, 49:1-14.
55. Risby T.H. Disease markers in exhaled breath. Disease markers in exhaled breath: mechanisms and clinical applications 2002, 113-122. IOS Press, Amsterdam. N. Marczin, M.H. Yacoub (Eds.).
56. Wang Z., Klipfell E., Bennett B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
57. Dummer J., Storer M., Swanney M., et al. Analysis of biogenic volatile organic compounds in human health and disease. Trends Anal Chem 2011, 30:960-967.
58. Duan Y.X., Cao W.Q. Current status of methods and techniques for breath analysis. Crit Rev Anal Chem 2007, 37:3-13.
59. Smith D., Spanel P. The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. Analyst 2007, 132:390-396.
60. Fens N., Zwinderman A., van der Schee M., et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009, 180:1076-1082.
61. Hunter G.W., Stetter J.R., Hesketh P.J., et al. Smart sensor systems. Interface Mag 2011, 66-69.
62. Liu C.C., Hesketh P., Hunter G.W. Chemical microsensors. ECS Interface 2004, 22-29.
63. Hunter G.W., Xu J.C., Makel D.B. Case studies in chemical sensor development. Bionanofluidic Mems 2008, 197-231. Springer Press, New York. P. Hesketh (Ed.).
64. Hunter G.W., Xu J.C., Dungan L.K., et al. Smart sensor systems for aerospace applications: from sensor development to application testing. ECS Transactions 2008, 16:333-344.
65. Hunter G.W., Xu J.C., Dungan L.K., et al. Smart chemical sensor systems for fire detection and environmental monitoring in spacecraft 2010.
66. Hunter G.W., Dweik R.A. Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications. J Breath Res 2008, 037020.
67. Hunter G.W., Xu J.C., Biaggi-Labiosa A.M., et al. Smart sensor systems for human health breath monitoring applications. J Breath Res 2011, 5:037111.
68. Francesco F.D., Loccioni C., Fioravanti M., et al. Implementation of Fowler's method for end-tidal air sampling. J Breath Res 2008, 2:1-10.
69. Horvath I., Hunt J., Barnes P.J., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523-548.
70. Dweik R.A., Amann A. Exhaled breath analysis: the new frontier in medical testing. J Breath Res 2008, 2:030301.
71. Mashir A., Dweik R.A. Exhaled breath analysis: the new interface between medicine and engineering. Adv Powder Technol 2009, 20:420-425.
72. Paschke K.M., Mashir A., Dweik R.A. Clinical applications of breath testing. F1000 medicine reports 2010, 2:56.
73. Grob N.M., Dweik R.A. Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology. J Breath Res 2008, 037002.
74. Pleil J.D., Lindstrom A.B. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds. Clin Chem 1997, 43:723-730.
75. Dweik R.A. The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity. J Breath Res 2011, 5:030201.